Reach Us +44-1647-403003
Journal of Cancer Science & Therapy|Volume 4, Issue 7 | 2012
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

2012: Volume 4, Issue 7

Transcutaneous Application of Carbon Dioxide (CO2) Enhances Chemosensitivity by Reducing Hypoxic Conditions in Human Malignant Fibrous Histiocytoma

Yasuo Onishi, Teruya Kawamoto, Takeshi Ueha, Hitomi Hara, Naomasa Fukase, Mitsunori Toda, Risa Harada, Yoshitada Sakai, Masahiko Miwa, Kotaro Nishida, Masahiro Kurosaka and Toshihiro Akisue

Research Article: J Cancer Sci Ther/Vol.4.7 174-181 (2012)

DOI: 10.4172/1948-5956.1000136

Phase II Study of Post-surgery Radiotherapy Combined with Recombinant Adeno-viral Human P53 Gene Therapy in Treatment of Oral Cancer

Sanxia Liu, Peng Chen, Min Hu, Ye Tao, Lijie Chen, Huawei Liu, Jiazhi Wang, Jinchao Luo and Gui Gao

Research Article: J Cancer Sci Ther/Vol.4.7 193-195 (2012)

DOI: 10.4172/1948-5956.1000140

Two Rare Examples of Extremely Indolent Nature of Renal Cell Carcinoma-Tumours Resectable and Curable Ten Years after Initial Diagnosis

Mohammad Shafi Wani, DV Singh, Sanjay Kumar Gupta, Aditya Ashok Pradhan, Yajvinder Prasad Singh Rana, Sandeep Harkar and Yogesh Kumar Swami

Case Report: J Cancer Sci Ther/Vol.4.7 196-198 (2012)

DOI: 10.4172/1948-5956.1000141

SF1126, a Pan-PI3K Inhibitor has Potent Pre-Clinical Activity in Aggressive B-Cell Non-Hodgkin Lymphomas by Inducing Cell Cycle Arrest and Apoptosis

Wenqing Qi, Amy Stejskal, Carla Morales, Laurence S Cooke, Joseph R Garlich and Daruka Mahadevan

Research Article: J Cancer Sci Ther/Vol.4.7 207-213 (2012)

DOI: 10.4172/1948-5956.1000143

Relevant Topics